CASR and coronary artery disorder: In the network pharmacology analysis, GO enrichment analysis revealed that CASR against CHD is involved in a number of biological processes, such as circulatory processes, response to steroids, and phospholipase C activating G protein-coupled receptor signaling pathway, which are directly related to the pathogenesis of CHD (Jayalalitha et al., 2008; Morgan et al., 2020; Nagoor et al., 2020).